Transforming Discovery into Opportunity

CDRD & Aequus are collaborating & sharing respective expertise that could lead to new cannabinoid therapeutics and a pathway to clinical trials, particularly in neurological movement disorders.

Read more…

Gordon McCauley, President and CEO of CDRD, and an expert panel explored the current challenges to health innovation and offers solutions to ensure a vibrant life sciences sector that pays economic and health dividends down the road.

View the video on Facebook

Join us at the 2nd Personalized Medicine Summit 2017, June 11-13 2017 at the University of British Columbia (UBC).

Details here

Meet Amber, Katrina from Pigeon Lake, AB, Lucas from Rorketon, MB and Destiny from Gift Lake, AB who have joined the CDRD team in our Target Validation and Analytical Chemistry divisions from May 15-19.

More about our special guests here…

NeuroCDRD, a new drug development platform jointly led by CDRD, the Montreal Neurological Institute and Hospital at McGill University (MNI), & Merck aims to accelerate the development of new treatments for ALS and Parkinson’s disease.

More details…

CDRD is proud to a founding partner of the Regenerative Medicine Alliance of Canada along with other founding members: CCRM; CellCan; Medicine by Design; Ontario Institute for Regenerative Medicine; ThéCell; Canadian Stem Cell Foundation, and Stem Cell Network.

More details here…

CDRD is a partner in one of 16 new collaborative research projects announced by BioCanRx. These projects are aimed at finding improved treatment options and outcomes for cancer patients and  developing clinical Chimeric Antigen Receptor modified T cell (CAR-T) manufacturing capabilities in Canada.

Find out how…

Health sciences researchers, entrepreneurs, and companies alike have the opportunity to collaborate with CDRD and thereby access its full suite of expertise, infrastructure, and broad partnerships and networks.

Find out how CDRD supports Canadian Small/Medium Enterprises (SMEs)……


  • Over 1,100 early-stage technologies evaluated for commercial potential
  • Over 200 projects on 134 distinct technologies
  • 56 technologies advanced toward commercialization and/or commercialized
  • 7 spin-off companies launched
  • 14 technologies out-licensed

What is CDRD?

Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.

We work in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.

In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country.

Since 2008, Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

Latest from the Blog

CDRD part of $1.5 million project with MNI to advance new treatments for Parkinson’s Disease

Microdermics Wins BCIC-New Ventures Competition & $10,000 in Commercial Support from CDRD


Latest from Twitter


A Shared Vision

  • Industry
  • Academia
  • Government

Sign up to our newsletter

Receive CDRD's e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.

© Copyright 2017 CDRD. All rights reserved.